Omalizumab re-treatment rates in chronic spontaneous urticaria.

Omalizumab re-treatment rates in chronic spontaneous urticaria.
Eur Ann Allergy Clin Immunol. 2020 May 07;:
Authors: Khan S, Sholtysek S
PMID: 32378397 [PubMed - as supplied by publisher]

Source: European Annals of Allergy and Clinical Immunology - May 8, 2020 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research